Brief: Genocea Biosciences Reports Quarterly Loss Per Share $0.09
01/11/2018 12:19
Nov 1 (Reuters) - Genocea Biosciences Inc GNCA.O :
* GENOCEA REPORTS THIRD QUARTER 2018 FINANCIAL AND OPERATING
RESULTS
* GENOCEA BIOSCIENCES INC QUARTERLY LOSS PER SHARE $0.09
* GENOCEA BIOSCIENCES-CONTINUES TO EXPLORE STRATEGIC
ALTERNATIVES
FOR GEN-003, PHASE 3-READY INVESTIGATIONAL IMMUNOTHERAPY FOR
TREATMENT OF GENITAL HERPES
Source text for Eikon: ID:nGNX17m5cf
Further company coverage: GNCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc